semaglutide step 5 results week by week: timeline from first dose to full results Two-year effects of semaglutide in – Weight regain and cardiometabolic effects

In clinical trials conducted by Novo Nordisk, participants who were administered semi-weekly doses of Wegovy lost an average of approximately 15% of their body weight over a period ranging from 68 weeks to more than two years

Research and Development Foundation of Dongguan Peoples Hospital (K202012)

Combined with baseline biomarkers (fasting insulin, glucose, lipids) and clinical history, this information helps clinicians understand why you might respond more strongly to one GLP-1 medication class over anothersupporting precision medicine rather than trial-and-error dosing

[5] [6] [7] Medical uses [edit] Medications based on incretins are used in the treatment of type 2 diabetes mellitus as well as the management of obesity

Semaglutide still suppresses appetite during this phase, but you may notice the appetite-suppressing effect feels different than during other parts of your cycle